CRC
Curi RMB Capital Portfolio holdings
AUM
$5.27B
This Quarter Return
+7.7%
1 Year Return
+16.35%
3 Year Return
+64.1%
5 Year Return
+119.5%
10 Year Return
+234.7%
AUM
$4.4B
AUM Growth
+$4.4B
(+5.6%)
Cap. Flow
-$35.2M
Cap. Flow
% of AUM
-0.8%
Top 10 Holdings %
Top 10 Hldgs %
18.85%
Holding
564
New
38
Increased
225
Reduced
191
Closed
24
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
$19.3M |
| 2 |
Target
TGT
|
$12.6M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$5.87M |
| 4 |
Schwab US Large- Cap ETF
SCHX
|
$5.54M |
| 5 |
Microsoft
MSFT
|
$5.53M |
Top Sells
| 1 |
Edwards Lifesciences
EW
|
$22.9M |
| 2 |
Charles River Laboratories
CRL
|
$12.4M |
| 3 |
Kenvue
KVUE
|
$12.3M |
| 4 |
Monolithic Power Systems
MPWR
|
$10.6M |
| 5 |
Diageo
DEO
|
$9.2M |
Sector Composition
| 1 | Technology | 20.36% |
| 2 | Financials | 16.56% |
| 3 | Healthcare | 11.19% |
| 4 | Industrials | 10.38% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
FIVE9
FIVN
$2.05B
| – | – |
-69,520
| Closed | -$3.07M |
|
|
DSM
552
BNY Mellon Strategic Municipal Bond Fund
DSM
$280M
| – | – |
-90,296
| Closed | -$536K |
|
553
DNP Select Income Fund
DNP
$3.67B
| – | – |
-12,316
| Closed | -$101K |
|
|
554
Diageo
DEO
$61.1B
| – | – |
-72,930
| Closed | -$9.2M |
|
555
CVS Health
CVS
$93B
| – | – |
-5,296
| Closed | -$313K |
|
556
Caribou Biosciences
CRBU
$176M
| – | – |
-153,964
| Closed | -$253K |
|
557
Clearside Biomedical
CLSD
$26.7M
| – | – |
-25,000
| Closed | -$32.5K |
|
558
CION Investment
CION
$532M
| – | – |
-55,000
| Closed | -$667K |
|
|
CHCT
559
Community Healthcare Trust
CHCT
$429M
| – | – |
-38,175
| Closed | -$893K |
|
560
Colony Bankcorp
CBAN
$297M
| – | – |
-100,000
| Closed | -$1.23M |
|
561
AutoZone
AZO
$70.1B
| – | – |
-79
| Closed | -$234K |
|
562
AN2 Therapeutics
ANTX
$35.3M
| – | – |
-45,942
| Closed | -$98.8K |
|
|
563
Charles River Laboratories
CRL
$7.99B
| – | – |
-60,256
| Closed | -$12.4M |
|